Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses

Area of Science:

• Virology
• Immunology
• Monoclonal Antibody Technology

Background:

• Poliovirus remains a significant public health concern, necessitating robust neutralization strategies.
• Development of targeted antiviral therapies is crucial for combating poliovirus infections.

Purpose of the Study:

• To establish and characterize hybridoma clones producing neutralizing antibodies specific to type 1 poliovirus.
• To assess the neutralization spectrum of antibodies derived from independent hybridoma clones against diverse type 1 poliovirus strains.

Main Methods:

• Generation of hybridoma cell lines through immunization and cell fusion techniques.
• Characterization of antibody specificity and neutralization capacity using various type 1 poliovirus strains.
• Phenotypic analysis of antibody-mediated neutralization against a panel of 15 type 1 poliovirus strains.

Main Results:

• Four distinct hybridoma clones were successfully established, each producing type 1 poliovirus-specific neutralizing antibodies.
• Antibody clone (i) neutralized all 15 tested strains.
• Antibody clones (ii), (iii), and (iv) exhibited distinct neutralization profiles, targeting the inducer strain, predominantly wild strains, or vaccine-related and some wild strains, respectively.

Conclusions:

• The study successfully generated diverse neutralizing monoclonal antibodies against type 1 poliovirus.
• These antibodies exhibit varied specificities, highlighting their potential for differential therapeutic applications in poliovirus infections.
• The characterized clones provide valuable tools for research and potential development of poliovirus neutralization therapies.